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Background: Depression is common in elderly stroke survivors and has been associated 
with systemic inflammation. We aimed to investigate an elderly population of Swedish stroke 
patients for evidence of sustained peripheral inflammation 18 months post-stroke and to identify 
if inflammation is associated with post-stroke depression at 18 months post-stroke.
Methods: The Barthel Index was used to measure the level of impairment in activities of daily 
living at 3 days post-stroke. Serum concentrations of inflammation markers, ie, C-reactive 
protein and white cell count, were measured in 149 stroke patients (mean age 81 ± 5.33 years, 
35% male) at 18 months post-stroke, and a comparison was made with an age-matched sample of 
elderly Swedish individuals who had not suffered a stroke. At the same visit, clinical depression 
was diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, Third 
Edition-Revised criteria. Severity of depression was assessed using the Montgomery-Asberg 
Depression Rating Scale (MADRS).
Results: Mean C-reactive protein and white cell count levels in stroke patients were signifi-
cantly elevated at 18 months post-stroke compared with population probands. Disability scores 
were associated with MADRS depression scores, but C-reactive protein and white cell count 
were not.
Conclusion: We found evidence for a sustained peripheral inflammatory response at 18 months 
post-stroke. C-reactive protein and white cell count were not associated with depression in this 
study.
Keywords: geriatric, inflammatory, ischemia, mood
Introduction
Ischemic and hemorrhagic stroke affects 16 million people worldwide annually, with 
the risk of stroke doubling with each decade of life after the age of 55 years.1 Post-
stroke depression is particularly common, affecting at least one third of all stroke 
patients, and adversely affecting the response to rehabilitation and quality of life.2 
A number of risk factors are associated with the presentation of post-stroke depressive 
symptomatology including stroke severity,3 severity of stroke disability,4 a history of 
prior stroke,4 a history of clinical depression,5 female gender,4,6,7 single relationship 
status,7 and cardiovascular disease.6 Recent research on post-stroke depression has 
begun to focus on the association between depression and inflammation-mediated 
apoptosis.8
Ischemic stroke induces a central and peripheral inflammatory response.9 The brain 
responds to ischemic injury with an acute and prolonged inflammatory response, char-
acterized by rapid infiltration of microglia, upregulation of proinflammatory  cytokines, 
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and infiltration into the ischemic tissue.10  Recruitment of 
neutrophils has been detected within the first 24 hours of adult 
stroke.11 Macrophage recruitment starts later, with elevations 
seen at 3 days after stroke onset.12 Peripheral inflammatory 
molecules, ie, interleukin (IL)-1β, IL-6, IL-18, and tumor 
necrosis factor alpha, are elevated within the first 24 hours, 
reach peak levels around 2–3 days, and remain elevated at 
3 months post-stroke.13–15 Peripheral C-reactive protein and 
white cell count are increased within 24 hours of stroke 
onset, correlate with infarct size, and remain elevated at 
even 3 and 12 months after stroke onset.16 The current study 
aimed to identify whether there was evidence for sustained 
peripheral inflammation 18 months post-stroke, as defined by 
elevated C-reactive protein and white blood cell expression 
in peripheral blood samples, compared with an age-matched 
nonstroke cohort.
Upregulation of inflammatory cytokines has also been 
associated with clinical depression.2 Relatively few studies 
have examined the association between inflammation and 
post-stroke depression. A recent study found a significant 
association between serum IL-18 measured at day 7 post-
stroke and Montgomery-Asberg Depression Rating Scale 
(MADRS) depression scores at 2 weeks and 6 months after 
stroke onset.17 Studies have also found nonsignificant trends 
for elevated C-reactive protein in patients with post-stroke 
depression measured within a month of stroke.18–20 However, 
to our knowledge, no studies have examined the association 
between the inflammatory markers, C-reactive protein and 
white cell count, and depression in elderly stroke survivors as 
long as 1.5 years after stroke. Thus, it is important to clarify 
if these factors correlate with the post-stroke depression that 
has already been shown to affect at least a third of a much 
studied cohort of elderly stroke patients.21,22 Given the risk 
factors described above, this study aimed to identify whether 
there was evidence for sustained peripheral inflammation 
18 months post-stroke, as defined by elevated C-reactive 
protein and white cell count expression, in peripheral blood 
samples compared with an age-matched cohort and to iden-
tify if the inflammatory markers, C-reactive protein and 
white cell count, female gender, cardiovascular  comorbidity, 
and impairment in activities of daily living post-stroke, are 
associated with post-stroke depression among chronic stroke 
survivors.
Materials and methods
Subjects and study protocol
Participants were selected from the Gothenburg 70+ Stroke 
study,23 that included individuals aged at least 70 years who 
presented to Sahlgrenska University Hospital, Gothenburg, 
Sweden, between February 1, 1993 and May 17, 1994 with 
an acute focal neurological deficit of no other apparent cause 
than cerebrovascular events and confirmed by routine investi-
gations and acute computed tomography scans. Patients were 
excluded if brain computed tomography showed extracere-
bral or subarachnoid hemorrhage or a cerebral tumor, or if 
the patient was comatose (n = 17, 20%). Patients were also 
excluded if they presented with symptoms beginning more 
than 7 days prior to admission, required specialized neuro-
logical care (n = 46, 53%), lived in a nursing home at the time 
of admission, or if there was no available bed in the stroke 
unit. Patients were later contacted by letter, and subsequently 
by phone, to arrange a hospital-based appointment 1.5 years 
after stroke. If unable to attend the hospital, the examination 
took place in the participants’ homes (n = 15, 10%). Relevant 
medical information obtained from participants included risk 
factors for stroke, including history of previous stroke and 
cardiovascular disease (predating the index stroke). Informed 
consent was provided following written and verbal informa-
tion to participants or their closest relatives. Ethics approval 
was granted by the ethics committee for medical research at 
the University of Gothenburg (33/94). Mean age at follow-up 
was 81 ± 5.33 (range 70.8–92.8) years.
Control reference data
Control participant reference data relating to C-reactive 
protein and white cell count were sourced from the National 
Health and Nutrition Examination Survey, 1999–2002, 
(n = 4472 men and 5212 women) and from the Cardiovas-
cular Health Study (n = 2227 men and 2924 women), which 
are large population-based studies of community-dwelling 
elderly individuals aged 80 years and over.24,25
Biomarker collection
C-reactive protein was analyzed from venous blood samples 
taken at 1.5 years after stroke drawn into gel tubes, turned 
over at least five times, and centrifuged according to the man-
ufacturer’s specifications for 10 minutes after  coagulation. 
Serum was separated and stored at room temperature until 
analysis with turbidimetry. White cell count was analyzed by 
automated particle count of white blood cells taken in ethyl-
enediamine tetra-acetic acid tubes at 1.5 years after stroke.
Diagnostic criteria
Assessments of depression were conducted by a 
 neurologist/psychiatrist (TL) unaware of lesion informa-
tion at the time of or during the interview (1.5 years after 
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stroke). Clinical depression was diagnosed according to 
DSM-III-R (Diagnostic and Statistical Manual Of Mental 
Disorders, Third Edition-Revised)26 criteria. Depressive 
symptomatology was assessed using the MADRS.27 The 
diagnostic procedure involved a consensus conference 
with a second neurologist and psychiatrist prior to deter-
mination of final diagnoses. The Barthel Index was used 
as a functional measure of independence in activities 
after stroke.28
Statistical methods
The statistical analysis was conducted using the SPSS 
version 18 package (SPSS Inc, Chicago, IL). Preliminary 
analyses were performed to ensure assumptions of normality, 
 linearity, and homoscedasticity were met. When assumptions 
were  violated, square-root transformations were performed 
to maintain a normal distribution. Transformed variables 
included C-reactive protein values and MADRS depression 
scores. All statistical analyses were performed using the trans-
formed values. Hierarchical multiple regression was used.
Results
Characteristics of observational  
cohort study population
Table 1 shows the characteristics of stroke survivors. Of the 
243 patients at stroke admission, 32% (n = 77) had passed 
away while 7% (n = 17) declined to participate, leaving 
149 volunteer patients at the 1.5-year follow-up. Of those 
participating, 66% were female (n = 67) and 34% were male 
(n = 35). Mean age at follow-up was 81 ± 5.33 (70.8–92.8) 
years. Female MADRS scores were one point higher than 
those observed among male participants. A higher per-
centage of men than women were diagnosed with major 
depression (17.1% versus 10.4%) and depressive disorder 
not otherwise specified (DDNOS, 8.6% versus 4.4%). More 
females were diagnosed with dysthymia (16.4% versus 
2.9%). Stroke disability scores were more severe among 
women than in men. More male than female participants had 
recurrent stroke (25.7% versus 10.4%) and cardiovascular 
disease (25.7% versus 23.9%). C-reactive protein levels 
and white cell counts were comparable between male and 
female participants.
Comparison of study population  
with literature-sourced control data
Independent-samples t-tests show that stroke survivors had 
significantly higher C-reactive protein levels (t[101] = 3.58, 
Table 1 Patient characteristics
 n Mean (SE) 
or % (n)
Median
Female
 Age, years 67 82.1 (0.62) 83.07
 MADrS 67 11.24 (1.06) 9
 Major depressive episode 67 10.4% (n = 7)
 Dysthymia 67 16.4% (n = 11)
 DDNOS 67 4.4% (n = 3)
 Stroke disability – mild 67 92.5% (n = 62)
 Stroke disability – moderate 67 4.5% (n = 2)
 Stroke disability – severe 67 3.0% (n = 2)
 Previous stroke 67 10.4% (n = 7)
 Previous heart disease 67 23.9% (n = 16)
 CrP (mg/L) 67 2.83 (0.10) 2.57
 WCC (109/L) 67 6.72 (0.23) 6.60
Male
 Age, years 35 79.70 (0.76) 79.98
 MADrS 35 10.15 (1.58) 7
 Major depressive episode 35 17.1% (n = 6)
 Dysthymia 35 2.9% (n = 1)
 DDNOS 35 8.6% (n = 3)
 Stroke disability – mild 35 85.7% (n = 30)
 Stroke disability – moderate 35 14.3% (n = 5)
 Stroke disability – severe 35 0% (n = 0)
 Previous stroke 35 25.7% (n = 9)
 Previous heart disease 35 25.7% (n = 9)
 CrP (mg/L) 35 2.71 (0.14) 2.45
 WCC (109/L) 35 6.40 (0.26) 6.20
Abbreviations: MADRS, Montgomery-Asberg Depression Rating Scale; DDNOS, 
depressive disorder not otherwise specified; CRP, C-reactive protein; WCC, white 
cell count.
P = 0.001) and white cell counts (t[101] = 2.21, P = 0.029) 
than individuals not affected by stroke.
Analysis of depression
Stroke patients diagnosed with depression had higher mean 
values for C-reactive protein and white cell count than those 
without depression (10.44 versus 10.17 for C-reactive pro-
tein and 6.85 versus 6.47 for white cell count). However, 
there was no significant difference in levels of C-reactive 
protein or white cell count between stroke patients diagnosed 
with major depression, dysthymia, or DDNOS and those 
that were not (t[101] = 0.09, P = 0.932 and t[101] = 1.04, 
P = 0.303, respectively).
Table 2 shows the nonstandardized (B) and standard-
ized (β) regression coefficients, the standard error of the 
coefficients (SE B), and the change in R2 after entry of each 
additional block of independent variables to the regression. 
To control for gender and stroke disability, which are strongly 
associated with post-stroke depression,3,6 these variables 
were entered together into the first block. Cardiovascular 
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and white cell count are elevated at 3 and 12 months after 
stroke.9,29 It is also consistent with a study involving immuno-
histopathological characterization of inflammatory molecule 
expression in 137 cases of post-mortem human cerebral infarct 
(where the age of lesions ranged from one day to 53 years after 
stroke onset), suggesting that chronic inflammation may per-
sist for years after stroke onset.12 Our results also showed that 
cardiovascular comorbidity was associated with depression at 
18 months post-stroke. Many risk factors for stroke, such as 
diabetes, hypertension, and atherosclerosis, are associated with 
elevated inflammatory profiles.30 Thus, it is likely that stroke 
patients have a pre-existing hyperinflammatory state that is 
associated with ischemic risk and recurrent stroke.31
Our analyses showed that, while C-reactive protein and 
white cell count were elevated among stroke survivors, these 
factors were not associated with MADRS depression scores 
or depression diagnosis (using DSM-III-R criteria for major 
depression, dysthymia or DDNOS). While different from some 
studies conducted in the general population, these results are 
consistent with results from other studies in patients with 
cardiovascular disease.32 Results are also consistent with 
our recent meta-analysis showing no association of post-
stroke depression with a variety of inflammatory mediators 
measured within one month after stroke (C-reactive protein, 
IL-18, IL-6, or tumor necrosis factor alpha).33 In particular, 
Jimenez et al,34 McKechnie et al,20 and Rothenburg35 found 
nonsignificant trends for higher levels of C-reactive protein in 
patients (recruited from stroke units) with post-stroke depres-
sion, measured 10–35 days after stroke onset and defined 
using DSM-IV (Diagnostic and Statistical Manual Of Mental 
Disorders, Fourth Edition, Text Revision) diagnostic criteria 
or by a cutoff score on the Center for Epidemiologic Studies 
Depression scale. White cell count has not previously been 
studied in relation to depression in stroke survivors. A recent 
study of the proinflammatory cytokine, serum IL-18, showed 
that serum IL-18 measured at 7 days was significantly associ-
ated with MADRS depression scores at 2 weeks and 6 months 
after stroke onset (n = 100).17 However, studies with fewer 
participants (n = 30 and n = 47) and using DSM-IV diagnos-
tic criteria to classify depression report nonsignificant trends 
for an association of IL-18 levels and post-stroke depression 
in the first 10 days after stroke.35,36 Trends for associations of 
other proinflammatory cytokines (IL-6 and tumor necrosis 
factor alpha) with post-stroke depression have also been 
reported at 7–30 days post-stroke.17,19,34 As expected, impair-
ment in activities of daily living at 3 days after stroke onset 
independently predicted MADRS depression scores. This is 
consistent with previous research indicating that the level of 
Table 2 results from hierarchical multiple regression analysis
B SE B β R2
Step 1 0.087
 Constant 5.23 0.76
 Gender -0.50 0.26 -0.18
 Stroke disability -0.62 0.27 -0.22*
Step 2 0.049
 Constant 5.10 0.75
 Gender -0.58 0.26 -0.21*
 Stroke disability -0.63 0.26 -0.23*
 Previous heart disease 0.61 0.29 0.20*
 Previous stroke 0.37 0.37 0.10
Step 3 0.013
 Constant 4.94 0.94
 Gender -0.56 0.26 -0.20*
 Stroke disability -0.66 0.26 -0.24*
 Previous heart disease 0.63 0.29 0.20*
 Previous stroke 0.37 0.36 0.10
 CrP (mg/L) 0.19 0.16 0.12
 WCC (109/L) -0.05 0.07 -0.06
Notes: Nonstandardized (B), and standardized (β) regression coefficients, standard 
error of coefficients (SE B), and change in R2 after each block of independent 
variables associated with depression at 1.5 years post-stroke, R2 = 0.01 for step 1, 
and 0.00 for steps 2 and 3. *P , 0.05. 
Abbreviations: CRP, C-reactive protein; WCC, white cell count.
disease and previous stroke have also been identified to cor-
relate highly with post-stroke depression, and therefore were 
entered into block two. The third block consisted of C-reactive 
protein and white cell count. Gender and stroke disability 
explained 8.7% of the variance in depression scores, with 
stroke disability contributing significantly to MADRS depres-
sion scores (t = -2.34; P = 0.02). Addition of cardiovascular 
disease and previous stroke explained an additional 4.9% of 
the variance in MADRS depression scores (the model as a 
whole explained a total of 13.6%), with a history of cardio-
vascular disease significantly predicting MADRS depression 
scores (t = 2.09; P = 0.04). Addition of C-reactive protein 
and white cell count explained an additional 1.3% of the 
variance in depression scores (the total amount explained 
by the model was 14.9%), but C-reactive protein and white 
cell count were not independently associated with MADRS 
depression scores.
Discussion
To our knowledge, this is the first observational cohort study to 
examine the relationship between peripheral inflammation and 
depression in elderly stroke survivors at 1.5 years after stroke. 
We provide evidence of a sustained peripheral inflammatory 
response characterized by elevated levels of C-reactive protein 
and total white cell count at 18 months after stroke. This is con-
sistent with previous research  indicating that C-reactive protein 
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post-stroke impairment predicts depression at 3,37 and 6 and 
123 months post-stroke.
One strength of our study, is the thorough diagnostic 
workup in stroke patients. However, an important meth-
odological limitation is that these data were collected in 
the 1990s, so DSM-III-R criteria were used to diagnose 
depression. Few studies have compared the diagnostic 
classification systems in relation to major  depression. 
In a study of 176 outpatients with unipolar depression, 
 DSM-III-R criteria diagnosed more patients with melan-
cholia (22.7%) than DSM-IV criteria (16.5%).38 In another 
study of 65 patients with unipolar depression, melancholic 
depression was diagnosed more frequently using DSM-IV 
(56.9%) than DSM-III-R criteria (50.8%).39 Thus, some 
misclassification was inevitable. Our findings would ben-
efit from replication with more markers of inflammation 
and with repeated measures of inflammatory markers in 
the same cohort. Measurement of inflammatory markers 
was performed on one occasion in this study. The results 
would be considered more robust with repeated measures of 
inflammatory markers over a period of time. While efforts 
were made to control for potentially confounding variables, 
infarct volume and brain volume were not available for 
assessment to add to our model.
Conclusion
The current study aimed to identify whether there was 
evidence for sustained peripheral inflammation 18 months 
following stroke as defined by elevated C-reactive pro-
tein and white cell count expression in peripheral blood 
samples compared with an age-matched cohort and to 
identify if the inflammatory markers, C-reactive protein 
and white cell count, were associated with post-stroke 
depression among chronic stroke survivors. In this study, 
elderly stroke survivors had elevated inflammatory mark-
ers 18 months post-stroke compared with age-matched 
population controls. However, this increased inflammatory 
state was not associated with depressive disorders, and 
thus cannot explain the increased prevalence of depres-
sion after stroke or distinguish those at an increased risk 
of depression.
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